RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression

Clinical trial NCT06420973 · RECRUITING

Trial details

NCT number: NCT06420973
Sponsor: Peking University Cancer Hospital & Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Carcinoma Fallopian Tube Carcinoma Primary Peritoneal Carcinoma

Start date: 2024-05-16
Primary completion: 2027-05-17
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.